Prot #B7981015: A Phase 2b/3 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of PF-06651600 in Adult and Adolescent Alopecia Areata (AA) Subjects with 50% or Greater Scalp Hair Loss

Project: Research project

Project Details

StatusActive
Effective start/end date3/26/193/26/22

Funding

  • INC Research, LLC (Prot #B7981015)
  • Pfizer Inc. (Prot #B7981015)